AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three months ended on December 31 was $1.38, a drop in actual terms of 17% compared […]
UBS has no interest in buying fellow Swiss lender Credit Suisse, the bank's Chairman Colm Kelleher said in a interview Read more
Earlier this week, the company announced a $3 billion investment over three years in its Data & AI practice. The Read more
Toyota shareholders backed the board and voted down the first resolution proposed in 18 years at an annual general meeting Read more
Japan’s benchmark Nikkei gauge surged on Tuesday, closing over 33,000 for the first time in 33 years, led by technology Read more
